Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada
| Autor: | Waqqas Afif, Brian Yan, Steven E. Gruchy, Geoffrey C. Nguyen, Chadwick Williams, Brian Bressler, Karen Wong, Cynthia H. Seow, Gilaad G. Kaplan, Shane M. Devlin, Jennifer Jones, Liliana Oliveira, Sophie Plamondon |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Canada
medicine.medical_specialty Best practice media_common.quotation_subject MEDLINE Inflammatory bowel disease Special Article 03 medical and health sciences 0302 clinical medicine Health care medicine Humans Quality (business) Clinical quality lcsh:RC799-869 Quality of care Intensive care medicine Quality Indicators Health Care Quality of Health Care media_common Hepatology business.industry Gastroenterology General Medicine Inflammatory Bowel Diseases medicine.disease digestive system diseases 3. Good health 030220 oncology & carcinogenesis Physical therapy Universal health care lcsh:Diseases of the digestive system. Gastroenterology 030211 gastroenterology & hepatology business |
| Zdroj: | Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 5, Pp 275-285 (2014) |
| ISSN: | 2291-2797 2291-2789 |
| DOI: | 10.1155/2014/941245 |
| Popis: | BACKGROUND: There is a paucity of published data regarding the quality of care of inflammatory bowel disease (IBD) in Canada. Clinical quality indicators are quantitative end points used to guide, monitor and improve the quality of patient care. In Canada, where universal health care can vary significantly among provinces, quality indicators can be used to identify potential gaps in the delivery of IBD care and standardize the approach to interprovincial management.METHODS: The Emerging Practice in IBD Collaborative (EPIC) group generated a shortlist of IBD quality indicators based on a comprehensive literature review. An iterative voting process was used to select quality indicators to take forward. In a face-to-face meeting with the EPIC group, available evidence to support each quality indicator was presented by the EPIC member aligned to it, followed by group discussion to agree on the wording of the statements. The selected quality indicators were then ratified in a final vote by all EPIC members.RESULTS: Eleven quality indicators for the management of IBD within the single-payer health care system of Canada were developed. These focus on accurate diagnosis, appropriate and timely management, disease monitoring, and prevention or treatment of complications of IBD or its therapy.CONCLUSIONS: These quality indicators are measurable, reflective of the evidence base and expert opinion, and define a standard of care that is at least a minimum that should be expected for IBD management in Canada. The next steps for the EPIC group involve conducting research to assess current practice across Canada as it pertains to these quality indicators and to measure the impact of each of these indicators on patient outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text